Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control

NCT ID: NCT03916991

Last Updated: 2019-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-12

Study Completion Date

2019-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study planned to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control in symptomatic and asymptomatic participants. We will follow a cross-over study design to compare the effect of hip focused neuromuscular activation exercise or a sham exercise on foot posture and lower extremity biomechanics. Foot posture will be assessed by Navicular Drop Test (NDT), and lower extremity neuromuscular control will be assessed with Star Excursion Y-Balance Test (SEBT-Y) and Frontal Plane Projection Angle (FPPA) during single leg squat before and after the experiments. The results of this study may provide scientific knowledge for a kinetic chain approach during functional foot rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

A cross-over study to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neuromuscular Exercise

Neuromuscular Exercise

Group Type EXPERIMENTAL

Exercise

Intervention Type OTHER

Hip focused Neuromuscular Activation Exercise

Control

No intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Sham Exercise

Sham Exercise

Group Type SHAM_COMPARATOR

Exercise

Intervention Type OTHER

Hip focused Neuromuscular Activation Exercise

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Hip focused Neuromuscular Activation Exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be included, participants should be between the ages of 18 and 45 years.

Exclusion Criteria

* Participants will be excluded from this study if they have a history of lower body trauma or surgery, or positive trendelenburg sign and slump test.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elif Turgut

Associate Proffessor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elif Turgut, PhD

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elif Turgut, PhD

Role: CONTACT

00903123051576

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GO16542

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.